Illumina Stock Price, News & Analysis (NASDAQ:ILMN)

$212.05 1.38 (0.66 %)
(As of 11/21/2017 04:00 PM ET)
Previous Close$210.67
Today's Range$209.72 - $212.33
52-Week Range$119.37 - $214.50
Volume503,191 shs
Average Volume956,087 shs
Market Capitalization$30.96 billion
P/E Ratio61.12
Dividend YieldN/A
Beta0.74

About Illumina (NASDAQ:ILMN)

Illumina logoIllumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc. (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations. Core Illumina's products and services serve customers in the research, clinical and applied markets, and enable the adoption of a range of genomic solutions. The Company's portfolio of integrated systems, consumables and analysis tools addresses the range of genomic complexity, price points, and throughput, enabling customers to select the solution for their research or clinical challenge. The Company provides reproductive-health solutions, including noninvasive prenatal testing (NIPT), preimplantation genetic screening and diagnosis, and neonatal and genetic health testing.


Industry, Sector and Symbol:
  • Industry: Advanced Medical Equipment & Technology
  • Sub-Industry: Life Sciences Tools & Services
  • Sector: Healthcare
  • Symbol: NASDAQ:ILMN
  • CUSIP: 45232710
  • Web: www.illumina.com
Debt:
  • Debt-to-Equity Ratio: 0.41%
  • Current Ratio: 4.22%
  • Quick Ratio: 3.73%
Price-To-Earnings:
  • Trailing P/E Ratio: 61.12
  • Forward P/E Ratio: 56.55
  • P/E Growth: 3.45
Sales & Book Value:
  • Annual Sales: $2.40 billion
  • Price / Sales: 12.91
  • Cash Flow: $4.65 per share
  • Price / Cash: 45.56
  • Book Value: $15.45 per share
  • Price / Book: 13.72
Profitability:
  • Trailing EPS: $5.30
  • Net Income: $462.64 million
  • Net Margins: 30.34%
  • Return on Equity: 19.42%
  • Return on Assets: 10.74%
Misc:
  • Employees: 5,500
  • Outstanding Shares: 146,000,000
 

Frequently Asked Questions for Illumina (NASDAQ:ILMN)

What is Illumina's stock symbol?

Illumina trades on the NASDAQ under the ticker symbol "ILMN."

How were Illumina's earnings last quarter?

Illumina, Inc. (NASDAQ:ILMN) announced its quarterly earnings data on Tuesday, October, 24th. The life sciences company reported $1.11 EPS for the quarter, beating the Zacks' consensus estimate of $0.99 by $0.12. The life sciences company earned $714 million during the quarter, compared to the consensus estimate of $692.77 million. Illumina had a net margin of 30.34% and a return on equity of 19.42%. The firm's revenue was up 17.6% compared to the same quarter last year. During the same quarter last year, the firm earned $0.97 earnings per share. View Illumina's Earnings History.

When will Illumina make its next earnings announcement?

Illumina is scheduled to release their next quarterly earnings announcement on Monday, January, 29th 2018. View Earnings Estimates for Illumina.

What guidance has Illumina issued on next quarter's earnings?

Illumina issued an update on its FY17 earnings guidance on Tuesday, October, 24th. The company provided earnings per share guidance of $3.73-3.78 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.65. The company issued revenue guidance of +13% to ~$2.71 billion, compared to the consensus revenue estimate of $2.68 billion.

Where is Illumina's stock going? Where will Illumina's stock price be in 2017?

20 Wall Street analysts have issued 12-month price objectives for Illumina's shares. Their forecasts range from $122.00 to $250.00. On average, they expect Illumina's stock price to reach $199.28 in the next twelve months. View Analyst Ratings for Illumina.

What are Wall Street analysts saying about Illumina stock?

Here are some recent quotes from research analysts about Illumina stock:

  • 1. According to Zacks Investment Research, "Illumina’s third-quarter 2017 performance was quite promising with the company delivering better-than-expected revenues and earnings figures. The top line was supported by solid uptake of sequencing consumables and instruments as well as microarray portfolios. Management is also hopeful that recent launches like NovaSeq S4 flow cell and reagent kit for its NovaSeq 6000 System will drive demand for NovaSeq. We look forward to the launch of NovaSeq Xp workflow. Also, the company’s launch of Nextera DNA Flex buoys optimism. Moreover, the company recently partnered with Telegraph Hill Partners to set up an independent entity. Accordingly, over the last three months, Illumina has been trading above the broader industry. On the flip side, weak margins owing to the NovaSeq launch, higher array services revenues and unfavorable product mix within sequencing consumables will continue to act as deterrents." (10/31/2017)
  • 2. Canaccord Genuity analysts commented, "Shipments to China grew +16% and we believe China is likely to be a double-digit grower for ILMN over the next several years, driven by the Chinese Precision Medicine Initiative," (8/7/2017)

Who are some of Illumina's key competitors?

Who are Illumina's key executives?

Illumina's management team includes the folowing people:

  • Jay T. Flatley, Executive Chairman of the Board (Age 64)
  • Francis A. deSouza, President, Chief Executive Officer, Director (Age 46)
  • Sam Samad, Chief Financial Officer, Senior Vice President (Age 47)
  • Marc A. Stapley, Executive Vice President, Chief Administrative Officer (Age 46)
  • Garret Hampton Ph.D., Executive Vice President - Clinical Genomics (Age 51)
  • Omead Ostadan, Executive Vice President - Operations, Products and Strategy (Age 45)
  • Mostafa Ronaghi Ph.D., Chief Technology Officer, Senior Vice President (Age 47)
  • Charles E. Dadswell, Senior Vice President, General Counsel, Secretary (Age 57)
  • Mark Van Oene, Senior Vice President, Chief Commercial Officer
  • Karen K. McGinnis, Vice President, Chief Accounting Officer, Principal Accounting Officer (Age 51)

Who owns Illumina stock?

Illumina's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Baillie Gifford & Co. (12.52%), Edgewood Management LLC (3.52%), Jennison Associates LLC (2.78%), Ameriprise Financial Inc. (1.72%), Mitsubishi UFJ Trust & Banking Corp (0.69%) and Legal & General Group Plc (0.47%). Company insiders that own Illumina stock include A Blaine Bowman, Charles Dadswell, Christian O Henry, Daniel Bradbury, David R Walt, Frances Arnold, Jay T Flatley, Karin Eastham, Marc Stapley, Michel Bouchard, Mostafa Ronaghi, Nicholas Naclerio, Oene Mark Van, Omead Ostadan, Paul L Bianchi, Robert S Epstein and Roy A Whitfield. View Institutional Ownership Trends for Illumina.

Who sold Illumina stock? Who is selling Illumina stock?

Illumina's stock was sold by a variety of institutional investors in the last quarter, including Jennison Associates LLC, Baillie Gifford & Co., SG Americas Securities LLC, Stifel Financial Corp, Edgewood Management LLC, State Treasurer State of Michigan, PGGM Investments and Douglas Lane & Associates LLC. Company insiders that have sold Illumina company stock in the last year include A Blaine Bowman, Charles Dadswell, Daniel Bradbury, Frances Arnold, Jay T Flatley, Marc Stapley, Michel Bouchard, Mostafa Ronaghi, Oene Mark Van and Omead Ostadan. View Insider Buying and Selling for Illumina.

Who bought Illumina stock? Who is buying Illumina stock?

Illumina's stock was acquired by a variety of institutional investors in the last quarter, including American Century Companies Inc., Los Angeles Capital Management & Equity Research Inc., Ameriprise Financial Inc., Scout Investments Inc., Axiom International Investors LLC DE, Sei Investments Co., Eagle Asset Management Inc. and First Trust Advisors LP. View Insider Buying and Selling for Illumina.

How do I buy Illumina stock?

Shares of Illumina can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Illumina's stock price today?

One share of Illumina stock can currently be purchased for approximately $212.05.

How big of a company is Illumina?

Illumina has a market capitalization of $30.96 billion and generates $2.40 billion in revenue each year. The life sciences company earns $462.64 million in net income (profit) each year or $5.30 on an earnings per share basis. Illumina employs 5,500 workers across the globe.

How can I contact Illumina?

Illumina's mailing address is 5200 Illumina Way, SAN DIEGO, CA 92122-4616, United States. The life sciences company can be reached via phone at +1-858-2024500 or via email at [email protected]


MarketBeat Community Rating for Illumina (NASDAQ ILMN)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  682 (Vote Outperform)
Underperform Votes:  680 (Vote Underperform)
Total Votes:  1,362
MarketBeat's community ratings are surveys of what our community members think about Illumina and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Illumina (NASDAQ:ILMN)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 8 Hold Ratings, 11 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $199.28 (6.02% downside)

Consensus Price Target History for Illumina (NASDAQ:ILMN)

Price Target History for Illumina (NASDAQ:ILMN)

Analysts' Ratings History for Illumina (NASDAQ:ILMN)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/25/2017Citigroup Inc.Boost Price TargetNeutral$180.00 -> $220.00N/AView Rating Details
10/25/2017Barclays PLCBoost Price TargetEqual Weight$150.00 -> $185.00N/AView Rating Details
10/25/2017Bank of America CorporationBoost Price TargetBuy$215.00 -> $240.00N/AView Rating Details
10/25/2017Wells Fargo & CompanyReiterated RatingMarket Perform$200.00 -> $205.00N/AView Rating Details
10/25/2017Robert W. BairdUpgradeNeutral -> Outperform$184.00 -> $228.00N/AView Rating Details
10/23/2017Janney Montgomery ScottUpgradeSell -> NeutralN/AView Rating Details
10/23/2017Deutsche Bank AGUpgradeHold -> Buy$195.00 -> $160.00N/AView Rating Details
10/12/2017Canaccord GenuityReiterated RatingBuy$215.00 -> $230.00N/AView Rating Details
10/9/2017Piper Jaffray CompaniesReiterated RatingOverweight$202.00 -> $226.00N/AView Rating Details
9/26/2017Goldman Sachs Group, Inc. (The)Reiterated RatingNeutral -> Neutral$200.00LowView Rating Details
9/13/2017ArgusBoost Price TargetBuy$205.00 -> $235.00LowView Rating Details
9/12/2017Leerink SwannReiterated RatingOutperform$207.00 -> $225.00LowView Rating Details
8/2/2017Cowen and CompanyReiterated RatingOutperform$200.00HighView Rating Details
8/2/2017J P Morgan Chase & CoReiterated RatingOverweight$250.00HighView Rating Details
8/2/2017First AnalysisUpgradeUnderweight -> Equal Weight$176.00HighView Rating Details
7/10/2017Morgan StanleyReiterated RatingUnderweight$115.00 -> $122.00HighView Rating Details
4/26/2017Cantor FitzgeraldBoost Price TargetNeutral -> Neutral$155.00 -> $170.00HighView Rating Details
3/19/2017BTIG ResearchReiterated RatingHoldMediumView Rating Details
2/27/2017Evercore ISIUpgradeHold -> Buy$190.00N/AView Rating Details
1/6/2017CL KingUpgradeNeutral -> BuyN/AView Rating Details
7/27/2016MizuhoBoost Price TargetNeutral$138.00 -> $148.00N/AView Rating Details
5/4/2016Stifel NicolausReiterated RatingBuy$215.00 -> $160.00N/AView Rating Details
5/3/2016NomuraLower Price TargetBuy$210.00 -> $180.00N/AView Rating Details
4/22/2016Avondale PartnersReiterated RatingMarket Perform$175.00 -> $160.00N/AView Rating Details
(Data available from 11/21/2015 forward)

Earnings

Earnings History and Estimates Chart for Illumina (NASDAQ:ILMN)

Earnings by Quarter for Illumina (NASDAQ:ILMN)

Earnings History by Quarter for Illumina (NASDAQ ILMN)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/29/2018$1.19N/AView Earnings Details
10/24/2017Q3 2017$0.99$1.11$692.77 million$714.00 millionViewN/AView Earnings Details
8/1/2017Q2 2017$0.68$0.82$642.38 million$662.00 millionViewListenView Earnings Details
4/25/2017Q1 2017$0.64$0.64$590.51 million$598.00 millionViewN/AView Earnings Details
1/31/2017Q416$0.82$0.85$612.50 million$619.00 millionViewListenView Earnings Details
11/1/2016Q316$0.87$0.97$628.06 million$607.00 millionViewListenView Earnings Details
7/26/2016Q2$0.73$0.86$31.91 million$600.00 millionViewListenView Earnings Details
5/3/2016Q1$0.74$0.71$596.33 million$572.00 millionViewListenView Earnings Details
2/2/2016Q415$0.82$0.81$576.39 million$591.50 millionViewListenView Earnings Details
10/20/2015Q315$0.79$0.80$568.60 million$550.00 millionViewListenView Earnings Details
7/21/2015Q215$0.77$0.80$541.05 million$539.00 millionViewListenView Earnings Details
4/21/2015Q115$0.72$0.91$524.35 million$539.00 millionViewListenView Earnings Details
1/27/2015Q414$0.78$0.87$503.83 million$512.00 millionViewListenView Earnings Details
10/20/2014Q314$0.56$0.77$451.20 million$481.00 millionViewListenView Earnings Details
7/23/2014Q214$0.51$0.57$426.50 million$448.00 millionViewListenView Earnings Details
4/22/2014Q114$0.44$0.53$391.50 million$421.00 millionViewListenView Earnings Details
1/28/2014Q413$0.44$0.45$382.06 million$387.00 millionViewListenView Earnings Details
10/21/2013Q313$0.40$0.45$343.42 million$357.00 millionViewListenView Earnings Details
7/23/2013Q2 2013$0.40$0.43$331.77 million$346.09 millionViewListenView Earnings Details
4/22/2013Q1 2013$0.39$0.46$310.64 million$330.96 millionViewListenView Earnings Details
1/28/2013Q4 2012$0.41$0.42$303.13 million$309.30 millionViewListenView Earnings Details
10/23/2012$0.39$0.41ViewN/AView Earnings Details
7/24/2012$0.36$0.40ViewN/AView Earnings Details
4/23/2012$0.32$0.36ViewN/AView Earnings Details
2/7/2012$0.30$0.35ViewN/AView Earnings Details
10/25/2011$0.23$0.22ViewN/AView Earnings Details
4/26/2011$0.31$0.35ViewN/AView Earnings Details
2/8/2011$0.29$0.29ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Illumina (NASDAQ:ILMN)
2017 EPS Consensus Estimate: $3.61
2018 EPS Consensus Estimate: $4.47
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.63$0.82$0.69
Q2 20173$0.65$0.85$0.72
Q3 20173$0.99$1.06$1.02
Q4 20173$1.16$1.19$1.18
Q1 20183$1.01$1.08$1.04
Q2 20183$1.02$1.14$1.06
Q3 20183$1.14$1.20$1.18
Q4 20182$1.14$1.23$1.19
Q1 20191$1.28$1.28$1.28
Q2 20191$1.31$1.31$1.31
Q3 20191$1.33$1.33$1.33
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Illumina (NASDAQ:ILMN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Illumina (NASDAQ ILMN)

Insider Ownership Percentage: 0.89%
Institutional Ownership Percentage: 90.76%
Insider Trades by Quarter for Illumina (NASDAQ:ILMN)
Insider Trades by Quarter for Illumina (NASDAQ:ILMN)

Insider Trades by Quarter for Illumina (NASDAQ ILMN)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/15/2017Marc StapleyEVPSell2,000$205.48$410,960.00View SEC Filing  
11/15/2017Oene Mark VanSVPSell1,250$207.76$259,700.00View SEC Filing  
11/13/2017Oene Mark VanSVPSell1,232$207.78$255,984.96View SEC Filing  
11/7/2017Jay T FlatleyDirectorSell20,000$210.59$4,211,800.00View SEC Filing  
11/3/2017Charles DadswellSVPSell1,609$207.88$334,478.92View SEC Filing  
10/26/2017Marc StapleyEVPSell2,000$206.88$413,760.00View SEC Filing  
10/24/2017Jay T FlatleyDirectorSell20,000$210.43$4,208,600.00View SEC Filing  
10/12/2017Oene Mark VanSVPSell1,250$207.21$259,012.50View SEC Filing  
10/10/2017Jay T FlatleyDirectorSell20,000$203.27$4,065,400.00View SEC Filing  
10/3/2017Charles DadswellSVPSell145$202.23$29,323.35View SEC Filing  
9/26/2017Jay T FlatleyDirectorSell20,000$200.16$4,003,200.00View SEC Filing  
9/12/2017Jay T FlatleyDirectorSell20,000$211.11$4,222,200.00View SEC Filing  
9/12/2017Oene Mark VanSVPSell9,729$211.33$2,056,029.57View SEC Filing  
9/7/2017Mostafa RonaghiSVPSell20,000$210.00$4,200,000.00View SEC Filing  
9/5/2017Charles DadswellSVPSell145$205.71$29,827.95View SEC Filing  
9/5/2017Marc StapleyEVPSell2,000$205.93$411,860.00View SEC Filing  
8/31/2017Michel BouchardInsiderSell5,390$202.11$1,089,372.90View SEC Filing  
8/30/2017Michel BouchardCAOSell616$200.00$123,200.00View SEC Filing  
8/29/2017Jay T FlatleyDirectorSell22,540$195.21$4,400,033.40View SEC Filing  
8/28/2017Jay T FlatleyDirectorSell2,540$197.39$501,370.60View SEC Filing  
8/15/2017Jay T FlatleyDirectorSell20,000$194.73$3,894,600.00View SEC Filing  
8/7/2017Omead OstadanEVPSell1,671$195.26$326,279.46View SEC Filing  
8/3/2017Charles DadswellSVPSell1,609$197.00$316,973.00View SEC Filing  
8/3/2017Marc StapleyEVPSell2,000$196.80$393,600.00View SEC Filing  
8/2/2017Jay T FlatleyDirectorSell20,000$176.43$3,528,600.00View SEC Filing  
8/2/2017Michel BouchardInsiderSell3,131$194.97$610,451.07View SEC Filing  
8/2/2017Mostafa RonaghiSVPSell10,000$195.00$1,950,000.00View SEC Filing  
7/18/2017Jay T FlatleyDirectorSell15,000$170.77$2,561,550.00View SEC Filing  
7/14/2017Marc StapleyEVPSell2,000$173.56$347,120.00View SEC Filing  
7/7/2017Omead OstadanEVPSell1,672$172.73$288,804.56View SEC Filing  
7/5/2017Jay T FlatleyDirectorSell15,000$172.92$2,593,800.00View SEC Filing  
7/3/2017Charles DadswellSVPSell145$174.24$25,264.80View SEC Filing  
6/23/2017Michel BouchardInsiderSell246$185.00$45,510.00View SEC Filing  
6/22/2017Jay T FlatleyDirectorSell20,000$178.21$3,564,200.00View SEC Filing  
6/12/2017Marc StapleyEVPSell2,000$170.85$341,700.00View SEC Filing  
6/8/2017Michel BouchardInsiderSell246$178.91$44,011.86View SEC Filing  
6/6/2017Jay T FlatleyDirectorSell20,000$180.24$3,604,800.00View SEC Filing  
6/5/2017Charles DadswellSVPSell145$184.75$26,788.75View SEC Filing  
6/1/2017Jay T FlatleyDirectorSell3,320$180.55$599,426.00View SEC Filing  
5/25/2017Frances ArnoldDirectorSell825$174.77$144,185.25View SEC Filing  
5/23/2017Jay T FlatleyDirectorSell15,000$175.53$2,632,950.00View SEC Filing  
5/10/2017A Blaine BowmanDirectorSell2,300$181.61$417,703.00View SEC Filing  
5/9/2017Jay T FlatleyDirectorSell20,000$184.14$3,682,800.00View SEC Filing  
5/9/2017Michel BouchardInsiderSell5,740$184.68$1,060,063.20View SEC Filing  
5/3/2017Charles DadswellSVPSell1,609$187.07$300,995.63View SEC Filing  
4/12/2017A Blaine BowmanDirectorSell3,000$172.72$518,160.00View SEC Filing  
4/7/2017Daniel BradburyDirectorSell600$172.79$103,674.00View SEC Filing  
3/24/2017Omead OstadanEVPSell1,672$170.00$284,240.00View SEC Filing  
3/21/2017Daniel BradburyDirectorSell600$163.56$98,136.00View SEC Filing  
2/17/2017Daniel BradburyDirectorSell600$162.80$97,680.00View SEC Filing  
2/13/2017Omead OstadanEVPSell2,173$163.10$354,416.30View SEC Filing  
2/8/2017A Blaine BowmanDirectorSell3,000$162.74$488,220.00View SEC Filing  
2/6/2017Charles DadswellSVPSell572$161.26$92,240.72View SEC Filing  
1/30/2017Omead OstadanEVPSell259$160.90$41,673.10View SEC Filing  
1/19/2017Omead OstadanEVPSell2,378$160.06$380,622.68View SEC Filing  
1/11/2017A Blaine BowmanDirectorSell3,000$162.89$488,670.00View SEC Filing  
1/10/2017Charles DadswellSVPSell116$161.60$18,745.60View SEC Filing  
1/4/2017Daniel BradburyDirectorSell600$135.01$81,006.00View SEC Filing  
12/15/2016Omead OstadanEVPSell2,000$126.16$252,320.00View SEC Filing  
12/12/2016Daniel BradburyDirectorSell600$123.42$74,052.00View SEC Filing  
12/8/2016Omead OstadanEVPSell3,000$121.63$364,890.00View SEC Filing  
12/1/2016Omead OstadanEVPSell3,000$133.30$399,900.00View SEC Filing  
11/14/2016Daniel BradburyDirectorSell600$136.34$81,804.00View SEC Filing  
10/7/2016Daniel BradburyDirectorSell600$184.36$110,616.00View SEC Filing  
10/4/2016Charles DadswellSVPSell116$182.38$21,156.08View SEC Filing  
9/20/2016Robert S EpsteinDirectorSell300$174.29$52,287.00View SEC Filing  
9/15/2016Marc StapleyEVPSell1,270$172.87$219,544.90View SEC Filing  
9/14/2016Daniel BradburyDirectorSell600$171.25$102,750.00View SEC Filing  
8/23/2016Jay T FlatleyDirectorSell20,000$172.99$3,459,800.00View SEC Filing  
8/22/2016Robert S EpsteinDirectorSell300$170.27$51,081.00View SEC Filing  
8/17/2016Daniel BradburyDirectorSell600$168.42$101,052.00View SEC Filing  
8/15/2016Jay T FlatleyDirectorSell10,000$170.00$1,700,000.00View SEC Filing  
8/12/2016Roy A WhitfieldDirectorSell4,000$167.22$668,880.00View SEC Filing  
8/9/2016Jay T FlatleyDirectorSell10,000$165.97$1,659,700.00View SEC Filing  
8/1/2016Jay T FlatleyDirectorSell10,000$170.00$1,700,000.00View SEC Filing  
7/27/2016Charles DadswellSVPSell8,632$155.00$1,337,960.00View SEC Filing  
7/26/2016Jay T FlatleyDirectorSell10,000$150.00$1,500,000.00View SEC Filing  
7/20/2016Robert S EpsteinDirectorSell1,200$150.00$180,000.00View SEC Filing  
7/18/2016Jay T FlatleyDirectorSell10,000$150.00$1,500,000.00View SEC Filing  
7/14/2016A Blaine BowmanDirectorSell5,000$147.14$735,700.00View SEC Filing  
7/11/2016Christian O HenryEVPSell716$141.89$101,593.24View SEC Filing  
6/16/2016A Blaine BowmanDirectorSell5,000$135.08$675,400.00View SEC Filing  
6/15/2016Christian O HenryEVPSell2,141$137.90$295,243.90View SEC Filing  
6/13/2016Roy A WhitfieldDirectorSell3,800$140.44$533,672.00View SEC Filing  
6/1/2016Karin EasthamDirectorSell5,000$145.35$726,750.00View SEC Filing  
5/25/2016Christian O HenryEVPSell2,141$144.73$309,866.93View SEC Filing  
5/17/2016Christian O HenryEVPSell2,141$140.84$301,538.44View SEC Filing  
5/12/2016A Blaine BowmanDirectorSell5,000$137.11$685,550.00View SEC Filing  
4/27/2016Christian O HenryEVPSell2,141$138.46$296,442.86View SEC Filing  
4/18/2016Christian O HenryEVPSell2,141$176.01$376,837.41View SEC Filing  
4/18/2016Paul L BianchiVPSell1,884$175.00$329,700.00View SEC Filing  
4/14/2016A Blaine BowmanDirectorSell5,000$172.94$864,700.00View SEC Filing  
4/13/2016Christian O HenryEVPSell12,500$175.00$2,187,500.00View SEC Filing  
4/13/2016Paul L BianchiVPSell6,681$175.00$1,169,175.00View SEC Filing  
4/12/2016Jay T FlatleyCEOSell20,000$170.05$3,401,000.00View SEC Filing  
4/12/2016Roy A WhitfieldDirectorSell4,000$170.00$680,000.00View SEC Filing  
4/7/2016David R WaltDirectorSell4,000$168.90$675,600.00View SEC Filing  
4/5/2016Christian O HenryEVPSell2,141$166.07$355,555.87View SEC Filing  
4/4/2016Charles DadswellSVPSell8,382$167.81$1,406,583.42View SEC Filing  
3/23/2016Christian O HenryEVPSell2,141$155.05$331,962.05View SEC Filing  
3/22/2016Jay T FlatleyCEOSell10,000$154.18$1,541,800.00View SEC Filing  
3/21/2016Daniel BradburyDirectorSell1,200$155.63$186,756.00View SEC Filing  
3/21/2016Nicholas NaclerioSVPSell4,520$154.25$697,210.00View SEC Filing  
3/17/2016A Blaine BowmanDirectorSell5,000$145.24$726,200.00View SEC Filing  
3/15/2016David R WaltDirectorSell4,000$149.99$599,960.00View SEC Filing  
3/14/2016Christian O HenryEVPSell5,892$155.91$918,621.72View SEC Filing  
3/8/2016Charles DadswellSVPSell8,382$155.63$1,304,490.66View SEC Filing  
3/8/2016Jay T FlatleyCEOSell10,000$154.49$1,544,900.00View SEC Filing  
3/8/2016Omead OstadanEVPSell4,516$156.09$704,902.44View SEC Filing  
3/7/2016Charles DadswellSVPSell116$155.00$17,980.00View SEC Filing  
2/23/2016Jay T FlatleyCEOSell10,000$152.49$1,524,900.00View SEC Filing  
2/17/2016Daniel BradburyDirectorSell1,700$154.74$263,058.00View SEC Filing  
2/12/2016Roy A. WhitfieldDirectorSell3,750$140.30$526,125.00View SEC Filing  
2/1/2016Omead OstadanEVPSell1,108$156.73$173,656.84View SEC Filing  
1/26/2016Jay T. FlatleyCEOSell20,000$171.70$3,434,000.00View SEC Filing  
1/13/2016Jay T. FlatleyCEOSell20,000$168.81$3,376,200.00View SEC Filing  
1/4/2016Daniel BradburyDirectorSell1,700$182.80$310,760.00View SEC Filing  
12/28/2015Charles DadswellSVPSell168$188.63$31,689.84View SEC Filing  
12/22/2015Jay T. FlatleyCEOSell25,000$185.38$4,634,500.00View SEC Filing  
12/14/2015Roy A. WhitfieldDirectorSell3,750$175.07$656,512.50View SEC Filing  
12/11/2015Omead OstadanEVPSell260$179.90$46,774.00View SEC Filing  
12/11/2015Paul L BianchiVPSell197$179.90$35,440.30View SEC Filing  
12/10/2015Daniel BradburyDirectorSell1,700$182.37$310,029.00View SEC Filing  
12/8/2015Jay T. FlatleyCEOSell25,000$177.11$4,427,750.00View SEC Filing  
11/27/2015Robert S EpsteinDirectorSell1,000$185.56$185,560.00View SEC Filing  
11/25/2015Jay T. FlatleyCEOSell5,000$180.00$900,000.00View SEC Filing  
11/24/2015Jay T. FlatleyCEOSell20,000$173.27$3,465,400.00View SEC Filing  
11/16/2015Jay T. FlatleyCEOSell10,000$170.00$1,700,000.00View SEC Filing  
11/10/2015Daniel BradburyDirectorSell1,700$154.03$261,851.00View SEC Filing  
11/10/2015Jay T. FlatleyCEOSell10,000$154.58$1,545,800.00View SEC Filing  
11/3/2015Charles DadswellSVPSell158$150.00$23,700.00View SEC Filing  
10/15/2015Jay T. FlatleyCEOSell10,000$150.00$1,500,000.00View SEC Filing  
10/7/2015Daniel BradburyDirectorSell1,700$145.81$247,877.00View SEC Filing  
9/29/2015David R WaltDirectorSell2,000$171.65$343,300.00View SEC Filing  
9/22/2015Jay T. FlatleyCEOSell25,000$192.79$4,819,750.00View SEC Filing  
9/15/2015David R WaltDirectorSell2,000$206.45$412,900.00View SEC Filing  
9/14/2015Daniel BradburyDirectorSell1,700$203.89$346,613.00View SEC Filing  
9/9/2015Paul L. BianchiVPSell1,245$199.32$248,153.40View SEC Filing  
9/8/2015Jay T. FlatleyCEOSell25,000$194.87$4,871,750.00View SEC Filing  
9/8/2015Karin EasthamDirectorSell4,300$195.76$841,768.00View SEC Filing  
9/4/2015Roy A. WhitfieldDirectorSell4,500$192.63$866,835.00View SEC Filing  
9/1/2015David R WaltDirectorSell2,000$195.08$390,160.00View SEC Filing  
8/27/2015Jay T. FlatleyCEOSell25,000$200.16$5,004,000.00View SEC Filing  
8/18/2015David R WaltDirectorSell2,000$206.89$413,780.00View SEC Filing  
8/17/2015Daniel BradburyDirectorSell1,700$208.14$353,838.00View SEC Filing  
8/13/2015Jay T FlatleyCEOSell25,000$207.85$5,196,250.00View SEC Filing  
8/5/2015Roy A. WhitfieldDirectorSell4,500$215.22$968,490.00View SEC Filing  
7/24/2015A Blaine BowmanDirectorSell3,000$221.47$664,410.00View SEC Filing  
7/23/2015Jay T FlatleyCEOSell25,000$214.87$5,371,750.00View SEC Filing  
7/21/2015David R WaltDirectorSell12,000$235.24$2,822,880.00View SEC Filing  
7/17/2015Mostafa RonaghiSVPSell1,200$235.00$282,000.00View SEC Filing  
7/16/2015Christian O HenrySVPSell5,390$229.61$1,237,597.90View SEC Filing  
7/15/2015Mostafa RonaghiSVPSell3,000$227.19$681,570.00View SEC Filing  
7/14/2015David R WaltDirectorSell10,000$227.39$2,273,900.00View SEC Filing  
7/13/2015Marc StapleyCFOSell3,000$214.90$644,700.00View SEC Filing  
7/13/2015Michel BouchardCAOSell1,400$222.75$311,850.00View SEC Filing  
7/10/2015Omead OstadanSVPSell1,110$219.81$243,989.10View SEC Filing  
7/10/2015Robert S EpsteinDirectorSell2,000$219.81$439,620.00View SEC Filing  
7/9/2015Jay T FlatleyCEOSell25,000$218.10$5,452,500.00View SEC Filing  
7/7/2015David R WaltDirectorSell10,000$220.22$2,202,200.00View SEC Filing  
7/6/2015Daniel BradburyDirectorSell1,700$219.70$373,490.00View SEC Filing  
6/30/2015David R WaltDirectorSell10,000$217.64$2,176,400.00View SEC Filing  
6/25/2015Jay T FlatleyCEOSell25,000$220.34$5,508,500.00View SEC Filing  
6/24/2015A Blaine BowmanDirectorSell3,000$221.43$664,290.00View SEC Filing  
6/24/2015Christian O HenrySVPSell5,084$221.07$1,123,919.88View SEC Filing  
6/23/2015David R WaltDirectorSell12,000$220.11$2,641,320.00View SEC Filing  
6/17/2015Christian O HenrySVPSell3,751$215.71$809,128.21View SEC Filing  
6/16/2015David R WaltDirectorSell10,000$215.14$2,151,400.00View SEC Filing  
6/15/2015Nicholas NaclerioSVPSell6,590$214.33$1,412,434.70View SEC Filing  
6/15/2015Paul L BianchiVPSell3,408$215.83$735,548.64View SEC Filing  
6/12/2015Marc StapleyCFOSell3,000$214.90$644,700.00View SEC Filing  
6/12/2015Michel BouchardCAOSell1,400$216.11$302,554.00View SEC Filing  
6/11/2015Jay T FlatleyCEOSell25,000$216.41$5,410,250.00View SEC Filing  
6/10/2015Christian O HenrySVPSell10,000$214.94$2,149,400.00View SEC Filing  
6/10/2015Robert S EpsteinDirectorSell2,000$214.24$428,480.00View SEC Filing  
6/5/2015Roy A WhitfieldDirectorSell4,500$207.49$933,705.00View SEC Filing  
6/2/2015David R WaltDirectorSell10,000$204.42$2,044,200.00View SEC Filing  
6/1/2015Karin EasthamDirectorSell5,000$205.24$1,026,200.00View SEC Filing  
5/29/2015Daniel BradburyDirectorSell1,700$206.62$351,254.00View SEC Filing  
5/28/2015Jay T FlatleyCEOSell25,000$208.78$5,219,500.00View SEC Filing  
5/22/2015A Blaine BowmanDirectorSell3,000$204.58$613,740.00View SEC Filing  
5/19/2015David R WaltDirectorSell10,000$202.00$2,020,000.00View SEC Filing  
5/14/2015Christian O HenrySVPSell3,751$198.52$744,648.52View SEC Filing  
5/14/2015Jay T FlatleyCEOSell25,000$197.76$4,944,000.00View SEC Filing  
5/13/2015Paul L BianchiVPSell3,356$197.14$661,601.84View SEC Filing  
5/11/2015Robert S EpsteinDirectorSell2,000$196.49$392,980.00View SEC Filing  
4/28/2015David R WaltDirectorSell7,000$183.88$1,287,160.00View SEC Filing  
4/24/2015A Blaine BowmanDirectorSell3,000$190.73$572,190.00View SEC Filing  
4/23/2015Jay T FlatleyCEOSell25,000$189.57$4,739,250.00View SEC Filing  
4/21/2015David R WaltDirectorSell10,000$197.95$1,979,500.00View SEC Filing  
4/15/2015Christian O HenrySVPSell3,751$189.02$709,014.02View SEC Filing  
4/14/2015David R WaltDirectorSell7,000$188.23$1,317,610.00View SEC Filing  
4/13/2015Marc StapleyCFOSell3,000$190.12$570,360.00View SEC Filing  
4/13/2015Michel BouchardCAOSell1,400$188.61$264,054.00View SEC Filing  
4/13/2015Paul L BianchiVPSell3,390$187.22$634,675.80View SEC Filing  
4/10/2015Robert S EpsteinDirectorSell2,000$186.99$373,980.00View SEC Filing  
4/9/2015Jay T FlatleyCEOSell25,000$184.55$4,613,750.00View SEC Filing  
4/8/2015Daniel BradburyDirectorSell1,700$185.32$315,044.00View SEC Filing  
4/7/2015David R WaltDirectorSell5,000$184.28$921,400.00View SEC Filing  
4/6/2015Roy A WhitfieldDirectorSell4,600$181.32$834,072.00View SEC Filing  
3/26/2015Jay T FlatleyCEOSell25,000$181.34$4,533,500.00View SEC Filing  
3/24/2015David R WaltDirectorSell5,000$192.16$960,800.00View SEC Filing  
3/17/2015A Blaine BowmanDirectorSell3,000$192.30$576,900.00View SEC Filing  
3/16/2015Gerald MoellerDirectorSell2,700$193.36$522,072.00View SEC Filing  
3/16/2015Nicholas NaclerioSVPSell6,590$193.94$1,278,064.60View SEC Filing  
3/13/2015Paul L BianchiVPSell3,390$186.67$632,811.30View SEC Filing  
3/12/2015Marc StapleyCFOSell3,314$189.01$626,379.14View SEC Filing  
3/10/2015Richard KlausnerSVPSell1,186$191.75$227,415.50View SEC Filing  
3/10/2015Robert S EpsteinDirectorSell3,000$191.75$575,250.00View SEC Filing  
2/26/2015Jay T FlatleyCEOSell25,000$195.73$4,893,250.00View SEC Filing  
2/12/2015Jay T FlatleyCEOSell25,000$194.64$4,866,000.00View SEC Filing  
2/3/2015David R WaltDirectorSell7,000$190.89$1,336,230.00View SEC Filing  
2/2/2015Karin EasthamDirectorSell10,000$192.77$1,927,700.00View SEC Filing  
2/2/2015Nicholas NaclerioSVPSell15,250$194.37$2,964,142.50View SEC Filing  
1/27/2015Charles DadswellSVPSell224$198.90$44,553.60View SEC Filing  
1/27/2015David R WaltDirectorSell4,000$201.76$807,040.00View SEC Filing  
1/22/2015Jay T FlatleyCEOSell25,000$188.48$4,712,000.00View SEC Filing  
1/20/2015William H RastetterDirectorSell16,000$188.99$3,023,840.00View SEC Filing  
1/15/2015Marc StapleyCFOSell1,422$181.62$258,263.64View SEC Filing  
1/8/2015Jay T FlatleyCEOSell25,000$197.62$4,940,500.00View SEC Filing  
1/6/2015David R WaltDirectorSell6,000$188.55$1,131,300.00View SEC Filing  
1/2/2015Karin EasthamDirectorSell10,000$185.63$1,856,300.00View SEC Filing  
12/30/2014David R WaltDirectorSell5,000$186.95$934,750.00View SEC Filing  
12/29/2014Gerald MoellerDirectorSell8,000$187.05$1,496,400.00View SEC Filing  
12/26/2014Jay T FlatleyCEOSell25,000$186.71$4,667,750.00View SEC Filing  
12/23/2014David R WaltDirectorSell7,000$184.55$1,291,850.00View SEC Filing  
12/16/2014David R WaltDirectorSell5,000$178.35$891,750.00View SEC Filing  
12/15/2014Marc StapleyCFOSell1,422$181.09$257,509.98View SEC Filing  
12/11/2014Jay T FlatleyCEOSell25,000$185.79$4,644,750.00View SEC Filing  
12/9/2014David R WaltDirectorSell7,000$186.75$1,307,250.00View SEC Filing  
12/8/2014Daniel BradburyDirectorSell1,600$190.14$304,224.00View SEC Filing  
12/4/2014Karin EasthamDirectorSell10,000$191.87$1,918,700.00View SEC Filing  
12/1/2014Mostafa RonaghiSVPSell10,000$188.46$1,884,600.00View SEC Filing  
11/26/2014Paul L BianchiSVPSell1,626$189.20$307,639.20View SEC Filing  
11/17/2014Roy A WhitfieldDirectorSell4,000$178.26$713,040.00View SEC Filing  
11/14/2014Marc StapleyCFOSell1,422$181.13$257,566.86View SEC Filing  
11/13/2014Daniel BradburyDirectorSell2,100$186.88$392,448.00View SEC Filing  
11/13/2014Jay T FlatleyCEOSell25,000$189.32$4,733,000.00View SEC Filing  
11/3/2014Michel BouchardCAOSell631$195.68$123,474.08View SEC Filing  
11/3/2014Mostafa RonaghiSVPSell10,000$195.66$1,956,600.00View SEC Filing  
10/30/2014Daniel BradburyDirectorSell2,100$191.83$402,843.00View SEC Filing  
10/23/2014Jay T FlatleyCEOSell25,000$189.54$4,738,500.00View SEC Filing  
10/13/2014Daniel BradburyDirectorSell2,100$152.03$319,263.00View SEC Filing  
10/9/2014Jay T FlatleyCEOSell25,000$163.49$4,087,250.00View SEC Filing  
10/7/2014A Blaine BowmanDirectorSell4,456$159.51$710,776.56View SEC Filing  
10/1/2014Daniel BradburyDirectorSell2,100$158.88$333,648.00View SEC Filing  
10/1/2014Mostafa RonaghiSVPSell10,000$159.81$1,598,100.00View SEC Filing  
9/30/2014A Blaine BowmanDirectorSell5,000$164.02$820,100.00View SEC Filing  
9/29/2014Gerald MoellerDirectorSell5,000$164.89$824,450.00View SEC Filing  
9/25/2014Jay T FlatleyCEOSell25,000$164.43$4,110,750.00View SEC Filing  
9/24/2014Christian O HenrySVPSell20,000$167.28$3,345,600.00View SEC Filing  
9/23/2014A Blaine BowmanDirectorSell5,000$168.50$842,500.00View SEC Filing  
9/16/2014A Blaine BowmanDirectorSell5,000$169.60$848,000.00View SEC Filing  
9/15/2014Daniel BradburyDirectorSell2,100$168.57$353,997.00View SEC Filing  
9/15/2014Jay T FlatleyCEOSell25,000$176.06$4,401,500.00View SEC Filing  
9/15/2014Marc StapleyCFOSell1,422$169.05$240,389.10View SEC Filing  
9/15/2014Nicholas NaclerioSVPSell2,000$169.53$339,060.00View SEC Filing  
9/9/2014A Blaine BowmanDirectorSell5,000$178.08$890,400.00View SEC Filing  
9/3/2014Christian O HenrySVPSell10,000$180.59$1,805,900.00View SEC Filing  
9/3/2014Daniel BradburyDirectorSell2,100$179.77$377,517.00View SEC Filing  
9/2/2014A Blaine BowmanDirectorSell5,000$179.67$898,350.00View SEC Filing  
9/2/2014Michel BouchardVPSell686$180.07$123,528.02View SEC Filing  
9/2/2014Mostafa RonaghiSVPSell10,000$179.66$1,796,600.00View SEC Filing  
8/28/2014Jay T FlatleyCEOSell30,000$178.98$5,369,400.00View SEC Filing  
8/26/2014A Blaine BowmanDirectorSell5,000$179.22$896,100.00View SEC Filing  
8/22/2014Daniel BradburyDirectorSell2,100$172.24$361,704.00View SEC Filing  
8/19/2014A Blaine BowmanDirectorSell5,000$171.70$858,500.00View SEC Filing  
8/15/2014Nicholas NaclerioSVPSell2,000$167.23$334,460.00View SEC Filing  
8/15/2014Roy A WhitfieldDirectorSell4,000$169.28$677,120.00View SEC Filing  
8/13/2014Christian O HenrySVPSell20,000$164.66$3,293,200.00View SEC Filing  
8/5/2014A Blaine BowmanDirectorSell5,000$159.91$799,550.00View SEC Filing  
8/4/2014Daniel BradburyDirectorSell2,100$159.77$335,517.00View SEC Filing  
8/1/2014Mostafa RonaghiSVPSell10,000$159.73$1,597,300.00View SEC Filing  
7/29/2014A Blaine BowmanDirectorSell5,000$166.89$834,450.00View SEC Filing  
7/29/2014Christian O HenrySVPSell10,000$167.40$1,674,000.00View SEC Filing  
7/24/2014Jay T FlatleyCEOSell30,000$175.43$5,262,900.00View SEC Filing  
7/23/2014Daniel BradburyDirectorSell2,100$177.87$373,527.00View SEC Filing  
7/15/2014Nicholas NaclerioSVPSell2,000$174.26$348,520.00View SEC Filing  
7/14/2014Marc StapleyCFOSell1,422$177.59$252,532.98View SEC Filing  
7/10/2014Jay T FlatleyCEOSell30,000$172.56$5,176,800.00View SEC Filing  
7/8/2014Daniel BradburyDirectorSell2,100$172.89$363,069.00View SEC Filing  
7/1/2014Mostafa RonaghiSVPSell10,000$179.47$1,794,700.00View SEC Filing  
6/30/2014Gerald MoellerDirectorSell5,000$178.97$894,850.00View SEC Filing  
6/27/2014Daniel BradburyDirectorSell2,100$171.65$360,465.00View SEC Filing  
6/26/2014Jay T FlatleyCEOSell30,000$170.11$5,103,300.00View SEC Filing  
6/24/2014Christian O HenrySVPSell10,000$172.60$1,726,000.00View SEC Filing  
6/16/2014Christian O HenrySVPSell20,000$169.73$3,394,600.00View SEC Filing  
6/16/2014Marc StapleyCFOSell1,422$169.25$240,673.50View SEC Filing  
6/12/2014Daniel BradburyDirectorSell2,100$171.17$359,457.00View SEC Filing  
6/12/2014Jay T FlatleyCEOSell30,000$172.25$5,167,500.00View SEC Filing  
6/2/2014Karin EasthamDirectorSell6,000$157.56$945,360.00View SEC Filing  
6/2/2014Michel BouchardCAOSell1,491$155.51$231,865.41View SEC Filing  
6/2/2014Mostafa RonaghiSVPSell10,000$156.93$1,569,300.00View SEC Filing  
5/22/2014Jay FlatleyCEOSell30,000$154.95$4,648,500.00View SEC Filing  
5/15/2014Nicholas NaclerioSVPSell2,000$141.72$283,440.00View SEC Filing  
5/15/2014Roy WhitfieldDirectorSell4,000$143.71$574,840.00View SEC Filing  
5/14/2014Daniel BradburyDirectorSell2,100$146.46$307,566.00View SEC Filing  
5/14/2014Marc StapleyCFOSell1,422$146.94$208,948.68View SEC Filing  
5/8/2014Jay FlatleyCEOSell30,000$143.59$4,307,700.00View SEC Filing  
5/2/2014Daniel BradburyDirectorSell2,100$139.66$293,286.00View SEC Filing  
5/1/2014Mostafa RonaghiSVPSell10,000$135.91$1,359,100.00View SEC Filing  
4/24/2014Jay FlatleyCEOSell30,000$150.80$4,524,000.00View SEC Filing  
4/15/2014Daniel BradburyDirectorSell2,100$131.29$275,709.00View SEC Filing  
4/15/2014Nicholas NaclerioSVPSell2,000$133.56$267,120.00View SEC Filing  
4/14/2014Marc StapleyCFOSell1,422$134.80$191,685.60View SEC Filing  
4/10/2014Jay FlatleyCEOSell30,000$139.90$4,197,000.00View SEC Filing  
4/4/2014Daniel BradburyDirectorSell2,100$138.44$290,724.00View SEC Filing  
4/1/2014Mostafa RonaghiSVPSell10,000$152.41$1,524,100.00View SEC Filing  
3/27/2014Jay FlatleyCEOSell30,000$140.11$4,203,300.00View SEC Filing  
3/19/2014Daniel BradburyDirectorSell2,100$161.14$338,394.00View SEC Filing  
3/17/2014Gerald MoellerDirectorSell10,000$161.92$1,619,200.00View SEC Filing  
3/17/2014Nicholas NaclerioSVPSell2,000$163.65$327,300.00View SEC Filing  
3/14/2014Marc StapleyCFOSell1,422$163.35$232,283.70View SEC Filing  
3/13/2014Jay FlatleyCEOSell30,000$165.96$4,978,800.00View SEC Filing  
3/11/2014Christian HenrySVPSell3,000$167.16$501,480.00View SEC Filing  
3/11/2014Michel BouchardCAOSell2,168$167.21$362,511.28View SEC Filing  
3/3/2014Michel BouchardCAOSell2,994$176.81$529,369.14View SEC Filing  
2/25/2014Michel BouchardCAOSell24,505$176.13$4,316,065.65View SEC Filing  
2/24/2014Roy WhitfieldDirectorSell2,000$175.26$350,520.00View SEC Filing  
2/18/2014Nicholas NaclerioSVPSell2,000$169.77$339,540.00View SEC Filing  
2/13/2014Jay FlatleyCEOSell30,000$160.43$4,812,900.00View SEC Filing  
2/7/2014Jay FlatleyCEOSell5,000$152.23$761,150.00View SEC Filing  
1/31/2014Marc StapleyCFOSell20,038$151.32$3,032,150.16View SEC Filing  
1/23/2014Jay FlatleyCEOSell30,000$142.30$4,269,000.00View SEC Filing  
1/9/2014Jay FlatleyCEOSell30,000$114.77$3,443,100.00View SEC Filing  
12/26/2013Jay FlatleyCEOSell30,000$107.88$3,236,400.00View SEC Filing  
12/17/2013Gregory HeathSVPSell1,875$102.68$192,525.00View SEC Filing  
10/30/2013Christian O HenrySVPSell6,000$93.29$559,740.00View SEC Filing  
10/30/2013David R WaltDirectorSell5,000$93.02$465,100.00View SEC Filing  
10/28/2013William H RastetterDirectorSell20,000$92.37$1,847,400.00View SEC Filing  
10/24/2013Jay T FlatleyCEOSell30,000$92.32$2,769,600.00View SEC Filing  
10/22/2013Nicholas NaclerioSVPSell20,000$90.00$1,800,000.00View SEC Filing  
10/17/2013Gregory HeathSVPSell1,875$82.09$153,918.75View SEC Filing  
10/16/2013David R WaltDirectorSell5,000$82.59$412,950.00View SEC Filing  
10/15/2013Nicholas NaclerioSVPSell4,000$81.32$325,280.00View SEC Filing  
10/10/2013Christian HenrySVPSell6,000$77.73$466,380.00View SEC Filing  
10/10/2013Jay FlatleyCEOSell20,000$77.75$1,555,000.00View SEC Filing  
10/2/2013David R WaltDirectorSell5,000$80.58$402,900.00View SEC Filing  
9/18/2013David WaltDirectorSell5,000$83.11$415,550.00View SEC Filing  
9/17/2013Gregory HeathSVPSell1,875$85.20$159,750.00View SEC Filing  
9/16/2013Jay FlatleyCEOSell30,000$83.27$2,498,100.00View SEC Filing  
9/16/2013Nicholas NaclerioSVPSell4,000$85.00$340,000.00View SEC Filing  
9/10/2013Gregory HeathSVPSell1,875$82.00$153,750.00View SEC Filing  
9/9/2013Paul L BianchiSVPSell1,627$79.03$128,581.81View SEC Filing  
9/5/2013Christian O HenrySVPSell9,000$78.17$703,530.00View SEC Filing  
9/4/2013David R WaltDirectorSell5,000$77.18$385,900.00View SEC Filing  
9/3/2013Nicholas NaclerioSVPSell59,000$76.91$4,537,690.00View SEC Filing  
9/3/2013Roy A WhitfieldDirectorSell2,000$78.49$156,980.00View SEC Filing  
8/30/2013Mark LewisSVPSell5,000$78.12$390,600.00View SEC Filing  
8/22/2013Jay FlatleyCEOSell20,000$78.65$1,573,000.00View SEC Filing  
8/21/2013David WaltDirectorSell5,000$78.34$391,700.00View SEC Filing  
8/15/2013Nicholas NaclerioSVPSell2,000$78.43$156,860.00View SEC Filing  
8/8/2013Jay FlatleyCEOSell20,000$78.07$1,561,400.00View SEC Filing  
8/7/2013David WaltDirectorSell5,000$78.29$391,450.00View SEC Filing  
8/2/2013Michel BouchardVPSell11,465$80.64$924,537.60View SEC Filing  
7/25/2013Christian O HenrySVPSell11,462$80.89$927,161.18View SEC Filing  
7/25/2013Jay T FlatleyCEOSell20,000$81.01$1,620,200.00View SEC Filing  
7/24/2013David R WaltDirectorSell4,600$81.44$374,624.00View SEC Filing  
7/24/2013Gregory HeathSVPSell209,533$82.00$17,181,706.00View SEC Filing  
7/24/2013Michel BouchardVPSell9,789$79.28$776,071.92View SEC Filing  
7/15/2013Nicholas NaclerioSVPSell2,000$74.50$149,000.00View SEC Filing  
7/11/2013Jay T FlatleyCEOSell20,000$74.90$1,498,000.00View SEC Filing  
7/11/2013Mostafa RonaghiSVPSell24,000$74.95$1,798,800.00View SEC Filing  
7/10/2013David R WaltDirectorSell5,000$74.26$371,300.00View SEC Filing  
7/10/2013Michel BouchardVPSell3,618$74.30$268,817.40View SEC Filing  
7/9/2013Christian O HenrySVPSell9,000$74.01$666,090.00View SEC Filing  
6/27/2013Jay T FlatleyCEOSell20,000$74.96$1,499,200.00View SEC Filing  
6/26/2013David R WaltDirectorSell5,000$75.36$376,800.00View SEC Filing  
6/26/2013Michel BouchardVPSell4,272$75.06$320,656.32View SEC Filing  
6/25/2013Tristan OrpinSVPSell35,000$71.98$2,519,300.00View SEC Filing  
6/17/2013Nicholas NaclerioSVPSell2,000$68.56$137,120.00View SEC Filing  
6/14/2013Christian O HenrySVPSell25,959$68.10$1,767,807.90View SEC Filing  
6/13/2013Jay T FlatleyCEOSell20,000$66.49$1,329,800.00View SEC Filing  
6/13/2013Tristan OrpinSVPSell47,667$66.55$3,172,238.85View SEC Filing  
6/12/2013David R WaltDirectorSell5,000$67.67$338,350.00View SEC Filing  
6/12/2013Michel BouchardVPSell5,170$68.64$354,868.80View SEC Filing  
6/11/2013Mostafa RonaghiSVPSell24,000$69.01$1,656,240.00View SEC Filing  
6/3/2013Karin EasthamDirectorSell10,000$70.34$703,400.00View SEC Filing  
5/31/2013Mark L LewisSVPSell13,000$71.72$932,360.00View SEC Filing  
5/30/2013Matthew L PosardSVPSell2,836$70.80$200,788.80View SEC Filing  
5/29/2013David R WaltDirectorSell5,000$70.92$354,600.00View SEC Filing  
5/29/2013Michel BouchardVPSell6,276$71.02$445,721.52View SEC Filing  
5/21/2013Jay T FlatleyCEOSell24,000$69.39$1,665,360.00View SEC Filing  
5/20/2013Marc StapleyCFOSell2,843$73.38$208,619.34View SEC Filing  
5/15/2013David R WaltDirectorSell5,000$70.73$353,650.00View SEC Filing  
5/15/2013Michel BouchardVPSell14,241$70.71$1,006,981.11View SEC Filing  
5/15/2013Nicholas NaclerioSVPSell2,000$70.72$141,440.00View SEC Filing  
5/13/2013Mostafa RonaghiSVPSell24,000$68.83$1,651,920.00View SEC Filing  
5/10/2013Tristan OrpinSVPSell25,000$69.60$1,740,000.00View SEC Filing  
5/9/2013Jay T FlatleyCEOSell20,000$66.63$1,332,600.00View SEC Filing  
5/7/2013Tristan OrpinSVPSell5,000$65.68$328,400.00View SEC Filing  
4/8/2013Christian CabouSVPSell16,500$55.00$907,500.00View SEC Filing  
4/8/2013Marc StapleyCFOSell9,175$55.00$504,625.00View SEC Filing  
4/8/2013William H RastetterDirectorSell20,000$54.95$1,099,000.00View SEC Filing  
3/11/2013Marc StapleyCFOSell4,468$53.71$239,976.28View SEC Filing  
11/8/2012Jay T FlatleyCEOSell5,000$47.99$239,950.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Illumina (NASDAQ ILMN)

Source:
DateHeadline
Illumina (ILMN) Wins Infringement Suit Against Premaitha Health and Ariosa DiagnosticsIllumina (ILMN) Wins Infringement Suit Against Premaitha Health and Ariosa Diagnostics
www.streetinsider.com - November 21 at 7:58 PM
Illumina Wins Infringement Suit Against Premaitha Health plc and Ariosa Diagnostics, Inc.Illumina Wins Infringement Suit Against Premaitha Health plc and Ariosa Diagnostics, Inc.
finance.yahoo.com - November 21 at 7:58 PM
William Blair Comments on Illumina, Inc.s FY2017 Earnings (ILMN)William Blair Comments on Illumina, Inc.'s FY2017 Earnings (ILMN)
www.americanbankingnews.com - November 21 at 7:58 AM
ETFs with exposure to Illumina, Inc. : November 20, 2017ETFs with exposure to Illumina, Inc. : November 20, 2017
finance.yahoo.com - November 20 at 8:14 PM
The Illuminating Company Announces "Merry & Bright" Holiday Lights Photo ContestThe Illuminating Company Announces "Merry & Bright" Holiday Lights Photo Contest
www.prnewswire.com - November 20 at 2:36 PM
Illumina’s (ILMN) Strong Earnings Visibility Keep it a BuyIllumina’s (ILMN) Strong Earnings Visibility Keep it a Buy
investorplace.com - November 18 at 2:10 AM
Illuminas (ILMN) Strong Earnings Visibility Keep it a Buy ... - Investorplace.comIllumina's (ILMN) Strong Earnings Visibility Keep it a Buy ... - Investorplace.com
www.investorplace.com - November 17 at 6:49 AM
Insider Selling: Illumina, Inc. (ILMN) EVP Sells 2,000 Shares of StockInsider Selling: Illumina, Inc. (ILMN) EVP Sells 2,000 Shares of Stock
www.americanbankingnews.com - November 16 at 8:37 PM
Illumina’s (ILMN) Strong Earnings Visibility Keep it a BuyIllumina’s (ILMN) Strong Earnings Visibility Keep it a Buy
investorplace.com - November 16 at 10:22 AM
Illumina, Inc. (ILMN) SVP Oene Mark Van Sells 1,232 SharesIllumina, Inc. (ILMN) SVP Oene Mark Van Sells 1,232 Shares
www.americanbankingnews.com - November 15 at 10:29 PM
Illumina, Inc. (ILMN) SVP Sells $259,700.00 in StockIllumina, Inc. (ILMN) SVP Sells $259,700.00 in Stock
www.americanbankingnews.com - November 15 at 10:27 PM
Illumina, Inc. (ILMN) Given Average Recommendation of "Hold" by BrokeragesIllumina, Inc. (ILMN) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - November 13 at 8:28 PM
ETFs with exposure to Illumina, Inc. : November 9, 2017ETFs with exposure to Illumina, Inc. : November 9, 2017
finance.yahoo.com - November 11 at 11:53 AM
Comparing Accelerate Diagnostics (AXDX) & Illumina (ILMN)Comparing Accelerate Diagnostics (AXDX) & Illumina (ILMN)
www.americanbankingnews.com - November 10 at 11:30 PM
Illumina (ILMN) a Buy on High-Level Sales GrowthIllumina (ILMN) a Buy on High-Level Sales Growth
investorplace.com - November 9 at 12:23 PM
Illumina (ILMN) Names Gary Guthart to its Board of DirectorsIllumina (ILMN) Names Gary Guthart to its Board of Directors
www.streetinsider.com - November 9 at 6:45 AM
Illumina, Inc. (ILMN) Director Jay T. Flatley Sells 20,000 SharesIllumina, Inc. (ILMN) Director Jay T. Flatley Sells 20,000 Shares
www.americanbankingnews.com - November 8 at 9:21 PM
Illumina (ILMN) Names Gary Guthart to its Board of Directors - StreetInsider.comIllumina (ILMN) Names Gary Guthart to its Board of Directors - StreetInsider.com
www.streetinsider.com - November 8 at 10:19 AM
Illumina (ILMN) Names Gary Guthart to its Board of Directors - StreetInsider.comIllumina (ILMN) Names Gary Guthart to its Board of Directors - StreetInsider.com
www.streetinsider.com - November 8 at 10:19 AM
Illumina Names Gary S. Guthart, Ph.D., to its Board of Directors, Adding Decades of Leadership Experience in HealthcareIllumina Names Gary S. Guthart, Ph.D., to its Board of Directors, Adding Decades of Leadership Experience in Healthcare
finance.yahoo.com - November 8 at 10:19 AM
Illumina Names Gary S. Guthart, Ph.D., to its Board of Directors, Adding Decades of Leadership Experience in HealthcareIllumina Names Gary S. Guthart, Ph.D., to its Board of Directors, Adding Decades of Leadership Experience in Healthcare
finance.yahoo.com - November 8 at 10:19 AM
Charles Dadswell Sells 1,609 Shares of Illumina, Inc. (ILMN) StockCharles Dadswell Sells 1,609 Shares of Illumina, Inc. (ILMN) Stock
www.americanbankingnews.com - November 8 at 12:22 AM
Illumina, Inc. (ILMN) Expected to Announce Quarterly Sales of $732.21 MillionIllumina, Inc. (ILMN) Expected to Announce Quarterly Sales of $732.21 Million
www.americanbankingnews.com - November 5 at 4:52 AM
Illumina’s (ILMN) Solid Sales Growth Keeps it a BuyIllumina’s (ILMN) Solid Sales Growth Keeps it a Buy
investorplace.com - November 3 at 9:35 AM
Earnings Review and Free Research Report: Illumina’s Revenue Advanced 18%; EPS Surged 28%Earnings Review and Free Research Report: Illumina’s Revenue Advanced 18%; EPS Surged 28%
finance.yahoo.com - November 3 at 9:35 AM
Illumina’s (ILMN) Solid Sales Growth Keeps it a BuyIllumina’s (ILMN) Solid Sales Growth Keeps it a Buy
investorplace.com - November 2 at 10:28 AM
Illumina, Inc. breached its 50 day moving average in a Bearish Manner : ILMN-US : October 31, 2017Illumina, Inc. breached its 50 day moving average in a Bearish Manner : ILMN-US : October 31, 2017
finance.yahoo.com - October 31 at 10:18 PM
Illumina, Inc. (ILMN) Rating Lowered to Hold at Zacks Investment ResearchIllumina, Inc. (ILMN) Rating Lowered to Hold at Zacks Investment Research
www.americanbankingnews.com - October 31 at 4:16 PM
Omnicell (OMCL) Earnings Beat, Revenues Miss Estimates in Q3Omnicell (OMCL) Earnings Beat, Revenues Miss Estimates in Q3
finance.yahoo.com - October 30 at 10:01 PM
ETFs with exposure to Illumina, Inc. : October 30, 2017ETFs with exposure to Illumina, Inc. : October 30, 2017
finance.yahoo.com - October 30 at 10:01 PM
TowerJazz and Yuanchen Microelectronics Announce Partnership for Backside Illumination (BSI) Manufacturing in Changchun, ChinaTowerJazz and Yuanchen Microelectronics Announce Partnership for Backside Illumination (BSI) Manufacturing in Changchun, China
feeds.benzinga.com - October 30 at 8:31 AM
Zacks Investment Research Upgrades Illumina, Inc. (ILMN) to "Buy"Zacks Investment Research Upgrades Illumina, Inc. (ILMN) to "Buy"
www.americanbankingnews.com - October 28 at 7:34 PM
ILMN Crosses Above Average Analyst TargetILMN Crosses Above Average Analyst Target
www.nasdaq.com - October 28 at 6:59 AM
Illumina, Inc. :ILMN-US: Earnings Analysis: Q3, 2017 By the Numbers : October 27, 2017Illumina, Inc. :ILMN-US: Earnings Analysis: Q3, 2017 By the Numbers : October 27, 2017
finance.yahoo.com - October 28 at 6:58 AM
Leerink Swann Comments on Illumina, Inc.s Q1 2019 Earnings (ILMN)Leerink Swann Comments on Illumina, Inc.'s Q1 2019 Earnings (ILMN)
www.americanbankingnews.com - October 27 at 6:54 PM
Q4 2017 EPS Estimates for Illumina, Inc. Raised by Analyst (ILMN)Q4 2017 EPS Estimates for Illumina, Inc. Raised by Analyst (ILMN)
www.americanbankingnews.com - October 27 at 12:44 PM
Illumina (ILMN) vs. Its Rivals Financial AnalysisIllumina (ILMN) vs. Its Rivals Financial Analysis
www.americanbankingnews.com - October 26 at 9:20 PM
Illumina, Inc. (ILMN) Director Sells $4,208,600.00 in StockIllumina, Inc. (ILMN) Director Sells $4,208,600.00 in Stock
www.americanbankingnews.com - October 26 at 8:32 PM
Earnings Momentum Keeps Illumina (ILMN) a Buy - Investorplace.comEarnings Momentum Keeps Illumina (ILMN) a Buy - Investorplace.com
www.investorplace.com - October 26 at 1:23 PM
Illumina (ILMN) Tops Q3 Earnings & Revenues, Raises Guidance - Yahoo FinanceIllumina (ILMN) Tops Q3 Earnings & Revenues, Raises Guidance - Yahoo Finance
finance.yahoo.com - October 26 at 1:23 PM
First Week of ILMN June 2018 Options Trading - NasdaqFirst Week of ILMN June 2018 Options Trading - Nasdaq
www.nasdaq.com - October 26 at 1:23 PM
5 Intriguing Things Illumina's Management Said in Its Q3 Update5 Intriguing Things Illumina's Management Said in Its Q3 Update
finance.yahoo.com - October 26 at 1:23 PM
Earnings Momentum Keeps Illumina (ILMN) a BuyEarnings Momentum Keeps Illumina (ILMN) a Buy
investorplace.com - October 26 at 10:19 AM
FY2017 EPS Estimates for Illumina, Inc. (ILMN) Raised by AnalystFY2017 EPS Estimates for Illumina, Inc. (ILMN) Raised by Analyst
www.americanbankingnews.com - October 26 at 9:36 AM
FY2017 EPS Estimates for Illumina, Inc. Increased by Analyst (ILMN)FY2017 EPS Estimates for Illumina, Inc. Increased by Analyst (ILMN)
www.americanbankingnews.com - October 26 at 9:36 AM
Illumina, Inc. (ILMN) PT Raised to $220.00Illumina, Inc. (ILMN) PT Raised to $220.00
www.americanbankingnews.com - October 25 at 7:16 PM
Illumina, Inc. (ILMN) PT Raised to $185.00Illumina, Inc. (ILMN) PT Raised to $185.00
www.americanbankingnews.com - October 25 at 7:16 PM
Wells Fargo & Company Reaffirms "Market Perform" Rating for Illumina, Inc. (ILMN)Wells Fargo & Company Reaffirms "Market Perform" Rating for Illumina, Inc. (ILMN)
www.americanbankingnews.com - October 25 at 8:03 AM
Illumina Inc. Reveals 13% Advance In Q3 Bottom Line - NasdaqIllumina Inc. Reveals 13% Advance In Q3 Bottom Line - Nasdaq
www.nasdaq.com - October 25 at 6:24 AM
Earnings Reaction History: Illumina, Inc., 30.0% Follow-Through ... - NasdaqEarnings Reaction History: Illumina, Inc., 30.0% Follow-Through ... - Nasdaq
www.nasdaq.com - October 25 at 6:24 AM

Social Media

Financials

Chart

Illumina (NASDAQ ILMN) Chart for Tuesday, November, 21, 2017
Loading chart…

This page was last updated on 11/21/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.